Abstract
Transforming growth factor-β (TGFβ) signaling acts as suppressor and inducer of tumor progression during the early and late stages of cancer, respectively. Some miRNAs have shown a regulatory effect on TGFβ signaling and here, we have used a combination of bioinformatics and experimental tools to show that hsa-miR-5590-3p is a regulator of multiple genes expression in the TGFβ signaling pathway. Consistent with the bioinformatics predictions, hsa-miR-5590-3p had a negative correlation of expression with TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 genes, detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Then, the dual luciferase assay supported the direct interaction between hsa-miR-5590-3p and TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4-3′UTR sequences. Consistently, the TGFβ-R1 protein level was reduced following the overexpression of hsa-miR-5590-3p, detected by Western analysis. Also, hsa-miR-5590-3p overexpression brought about the downregulation of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 expression in HCT-116 cells, detected by RT-qPCR, followed by cell cycle arrest in the sub-G1 phase, detected by flow cytometry. RT-qPCR results indicated that hsa-miR-5590-3p is significantly downregulated in breast tumor tissues (late stage) compared to their normal pairs. Altogether, data introduces hsa-miR-5590-3p as a negative regulator of the TGFβ/SMAD signaling pathway which acts through downregulation of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts. Therefore, it can be tested as a therapy target in cancers in which the TGFβ/SMAD pathway is deregulated.
Acknowledgments
The authors would like to thank 4402 lab mates TMU. This work has been supported by Tarbiat Modares University financial aids.
Conflict of interest statement: The authors declare that there are no conflicts of interest with any financial organization regarding the material discussed in the manuscript.
References
Baker, A.M., Cox, T.R., Bird, D., Lang, G., Murray, G.I., Sun, X.F., Southall, S.M., Wilson, J.R., and Erler, J.T. (2011). The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J. Natl. Cancer Inst. 103, 407–424.10.1093/jnci/djq569Suche in Google Scholar PubMed
Bissey, P.A., Law, J.H., Bruce, J.P., Shi, W., Renoult, A., Chua, M.L.K., Yip, K.W., and Liu, F.F. (2018). Dysregulation of the MiR-449b target TGFBI alters the TGFbeta pathway to induce cisplatin resistance in nasopharyngeal carcinoma. Oncogenesis 7, 40.10.1038/s41389-018-0050-xSuche in Google Scholar PubMed PubMed Central
Biswas, S., Trobridge, P., Romero-Gallo, J., Billheimer, D., Myeroff, L.L., Willson, J.K., Markowitz, S.D., and Grady, W.M. (2008). Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer 47, 95–106.10.1002/gcc.20511Suche in Google Scholar PubMed
Chiechi, A., Waning, D.L., Stayrook, K.R., Buijs, J.T., Guise, T.A., and Mohammad, K.S. (2013). Role of TGF-β in breast cancer bone metastases. Adv. Biosci. Biotechnol. 4, 15–30.10.4236/abb.2013.410A4003Suche in Google Scholar PubMed PubMed Central
Derry, M., Raina, K., Agarwal, R., and Agarwal, C. (2013). Differential effects of grape seed extract against human colorectal cancer cell lines: the intricate role of death receptors and mitochondria. Cancer Lett. 334, 69–78.10.1016/j.canlet.2012.12.015Suche in Google Scholar PubMed PubMed Central
Derry, M.M., Somasagara, R.R., Raina, K., Kumar, S., Gomez, J., Patel, M., Agarwal, R., and Agarwal, C. (2014). Target identification of grape seed extract in colorectal cancer using drug affinity responsive target stability (DARTS) technique: role of endoplasmic reticulum stress response proteins. Curr. Cancer Drug Targets 14, 323–336.10.2174/1568009614666140411101942Suche in Google Scholar PubMed PubMed Central
Dokanehiifard, S., Yasari, A., Najafi, H., Jafarzadeh, M., Nikkhah, M., Mowla, S.J., and Soltani, B.M. (2017). A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens. J. Biol. Chem. 292, 7566–7577.10.1074/jbc.M116.760710Suche in Google Scholar PubMed PubMed Central
Ekhteraei-Tousi, S., Mohammad-Soltani, B., Sadeghizadeh, M., Mowla, S.J., Parsi, S., and Soleimani, M. (2015). Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling. J. Cell Biochem. 116, 179–191.10.1002/jcb.24957Suche in Google Scholar PubMed
Elliott, B., Zackery, D.L., Eaton, V.A., Jones, R.T., Abebe, F., Ragin, C.C., and Khan, S.A. (2018). Ethnic differences in TGFβ signaling pathway may contribute to prostate cancer health disparity. Carcinogenesis 39, 546–555.10.1093/carcin/bgy020Suche in Google Scholar PubMed PubMed Central
Fang, F., Huang, B., Sun, S., Xiao, M., Guo, J., Yi, X., Cai, J., and Wang, Z. (2018). miR-27a inhibits cervical adenocarcinoma progression by downregulating the TGF-betaRI signaling pathway. Cell Death Dis. 9, 395.10.1038/s41419-018-0431-2Suche in Google Scholar PubMed PubMed Central
Genovese, G., Ergun, A., Shukla, S.A., Campos, B., Hanna, J., Ghosh, P., Quayle, S.N., Rai, K., Colla, S., Ying, H., et al. (2012). microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-beta signaling in glioblastoma. Cancer Discov. 2, 736–749.10.1158/2159-8290.CD-12-0111Suche in Google Scholar PubMed PubMed Central
Humbert, L., Neel, J., and Lebrun, J. (2010). Targeting TGF-β signaling in human cancer therapy. Trends Cell Mol. Biol. 5, 69–107.Suche in Google Scholar
Ikushima, H., and Miyazono, K. (2010). TGF-β signalling: a complex web in cancer progression. Nat. Rev. Cancer 10, 415–424.10.1038/nrc2853Suche in Google Scholar PubMed
Islam, F., Haque, M.H., Yadav, S., Islam, M.N., Gopalan, V., Nguyen, N.T., Lam, A.K., and Shiddiky, M.J. (2017). An electrochemical method for sensitive and rapid detection of FAM134B protein in colon cancer samples. Sci. Rep. 7, 133.10.1038/s41598-017-00206-8Suche in Google Scholar PubMed PubMed Central
Jafarzadeh, M., Soltani, B.M., Tousi, S.E., and Behmanesh, M. (2018). Hsa-miR-497 as a new regulator in TGFbeta signaling pathway and cardiac differentiation process. Gene 675, 150–156.10.1016/j.gene.2018.06.098Suche in Google Scholar PubMed
Kleczko, E.K. and Heasley, L.E. (2018). Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities. Mol. Cancer 17, 60.10.1186/s12943-018-0816-ySuche in Google Scholar PubMed PubMed Central
Kloosterman, W.P. and Plasterk, R.H. (2006). The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441–450.10.1016/j.devcel.2006.09.009Suche in Google Scholar PubMed
Lebrun, J.J. (2012). The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis. ISRN Mol. Biol. 2012, 381428.10.5402/2012/381428Suche in Google Scholar PubMed PubMed Central
Levy, L. and Hill, C.S. (2006). Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17, 41–58.10.1016/j.cytogfr.2005.09.009Suche in Google Scholar PubMed
Li, T., Kuang, Y., and Li, B. (2016). The genetic variants in 3′ untranslated region of voltage-gated sodium channel α1 subunit gene affect the mRNA-microRNA interactions and associate with epilepsy. BMC Genet. 17, 111.10.1186/s12863-016-0417-ySuche in Google Scholar PubMed PubMed Central
Lin, C., Zhang, J., Lu, Y., Li, X., Zhang, W., Zhang, W., Lin, W., Zheng, L., and Li, X. (2018). NIT1 suppresses tumour proliferation by activating the TGFβ1-Smad2/3 signalling pathway in colorectal cancer. Cell Death Dis. 9, 263.10.1038/s41419-018-0333-3Suche in Google Scholar PubMed PubMed Central
Massague, J. (2012). TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616–630.10.1038/nrm3434Suche in Google Scholar PubMed PubMed Central
Millet, C. and Zhang, Y.E. (2007). Roles of Smad3 in TGF-β signaling during carcinogenesis. Crit. Rev. Eukaryot Gene Expr. 17, 281–293.10.1615/CritRevEukarGeneExpr.v17.i4.30Suche in Google Scholar PubMed PubMed Central
Mishra, S., Deng, J.J., Gowda, P.S., Rao, M.K., Lin, C.L., Chen, C.L., Huang, T., and Sun, L.Z. (2014). Androgen receptor and microRNA-21 axis downregulates transforming growth factor β receptor II (TGFBR2) expression in prostate cancer. Oncogene 33, 4097–4106.10.1038/onc.2013.374Suche in Google Scholar PubMed PubMed Central
Morikawa, M., Derynck, R., and Miyazono, K. (2016). TGF-β and the TGF-β Family: context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. 8: a021873.10.1101/cshperspect.a021873Suche in Google Scholar PubMed PubMed Central
Najafi, H., Soltani, B.M., Dokanehiifard, S., Nasiri, S., and Mowla, S.J. (2017). Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway. RNA 23, 70–85.10.1261/rna.056317.116Suche in Google Scholar PubMed PubMed Central
Neuzillet, C., Tijeras-Raballand, A., Cohen, R., Cros, J., Faivre, S., Raymond, E., and de Gramont, A. (2015). Targeting the TGFbeta pathway for cancer therapy. Pharmacol Ther 147, 22–31.10.1016/j.pharmthera.2014.11.001Suche in Google Scholar PubMed
Palmero, E.I., de Campos, S.G., Campos, M., de Souza, N.C., Guerreiro, I.D., Carvalho, A.L., and Marques, M.M. (2011). Mechanisms and role of microRNA deregulation in cancer onset and progression. Genet Mol. Biol. 34, 363–370.10.1590/S1415-47572011000300001Suche in Google Scholar PubMed PubMed Central
Pickup, M., Novitskiy, S., and Moses, H.L. (2013). The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer 13, 788–799.10.1038/nrc3603Suche in Google Scholar PubMed PubMed Central
Prunier, C., Mazars, A., Noe, V., Bruyneel, E., Mareel, M., Gespach, C., and Atfi, A. (1999). Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion. J. Biol. Chem. 274, 22919–22922.10.1074/jbc.274.33.22919Suche in Google Scholar PubMed
Schniewind, B., Groth, S., Sebens Muerkoster, S., Sipos, B., Schafer, H., Kalthoff, H., Fandrich, F., and Ungefroren, H. (2007). Dissecting the role of TGF-β type I receptor/ALK5 in pancreatic ductal adenocarcinoma: smad activation is crucial for both the tumor suppressive and prometastatic function. Oncogene 26, 4850–4862.10.1038/sj.onc.1210272Suche in Google Scholar PubMed
Schoepp, M., Strose, A.J., and Haier, J. (2017). Dysregulation of miRNA expression in cancer associated fibroblasts (CAFs) and its consequences on the tumor microenvironment. Cancers (Basel) 9, 54.10.3390/cancers9060054Suche in Google Scholar PubMed PubMed Central
Siegel, P.M. and Massague, J. (2003). Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3, 807–821.10.1038/nrc1208Suche in Google Scholar PubMed
Tauriello, D.V.F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Canellas, A., Hernando-Momblona, X., et al. (2018). TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538–543.10.1038/nature25492Suche in Google Scholar PubMed
van der Pluijm, G. (2011). Epithelial plasticity, cancer stem cells and bone metastasis formation. Bone 48, 37–43.10.1016/j.bone.2010.07.023Suche in Google Scholar PubMed
van Kouwenhove, M., Kedde, M., and Agami, R. (2011). MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat. Rev. Cancer 11, 644–656.10.1038/nrc3107Suche in Google Scholar PubMed
Weiss, A. and Attisano, L. (2013). The TGFβ superfamily signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 2, 47–63.10.1002/wdev.86Suche in Google Scholar PubMed
Xia, Q., Li, C., Bian, P., Wang, J., and Dong, S. (2014). Targeting SMAD3 for inhibiting prostate cancer metastasis. Tumour Biol. 35, 8537–8541.10.1007/s13277-014-2368-0Suche in Google Scholar PubMed
Xu, J. and Attisano, L. (2000). Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor β signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 97, 4820–4825.10.1073/pnas.97.9.4820Suche in Google Scholar PubMed PubMed Central
Yi, H., Geng, L., Black, A., Talmon, G., Berim, L., and Wang, J. (2017). The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis. Oncogene 36, 3477–3489.10.1038/onc.2016.499Suche in Google Scholar PubMed PubMed Central
Yu, Y., Kanwar, S.S., Patel, B.B., Oh, P.S., Nautiyal, J., Sarkar, F.H., and Majumdar, A.P. (2012). MicroRNA-21 induces stemness by downregulating transforming growth factor β receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis 33, 68–76.10.1093/carcin/bgr246Suche in Google Scholar PubMed PubMed Central
Zhang, L., Zhou, F., and ten Dijke, P. (2013). Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. Trends Biochem. Sci. 38, 612–620.10.1016/j.tibs.2013.10.001Suche in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Reviews
- Complexity of type IV collagens: from network assembly to function
- Structural and mechanistic aspects of S-S bonds in the thioredoxin-like family of proteins
- Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
- Research Articles/Short Communications
- Genes and Nucleic Acids
- Dynamic characteristics of the mitochondrial genome in SCNT pigs
- Protein Structure and Function
- Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1
- Molecular Medicine
- The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity
- MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves’ disease
- Cell Biology and Signaling
- Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
- LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis
- Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts
Artikel in diesem Heft
- Frontmatter
- Reviews
- Complexity of type IV collagens: from network assembly to function
- Structural and mechanistic aspects of S-S bonds in the thioredoxin-like family of proteins
- Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
- Research Articles/Short Communications
- Genes and Nucleic Acids
- Dynamic characteristics of the mitochondrial genome in SCNT pigs
- Protein Structure and Function
- Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1
- Molecular Medicine
- The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity
- MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves’ disease
- Cell Biology and Signaling
- Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis
- LncRNA TINCR/microRNA-107/CD36 regulates cell proliferation and apoptosis in colorectal cancer via PPAR signaling pathway based on bioinformatics analysis
- Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts